prednisolone has been researched along with Mast Cell Activation Disease in 7 studies
Prednisolone: A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states.
prednisolone : A glucocorticoid that is prednisone in which the oxo group at position 11 has been reduced to the corresponding beta-hydroxy group. It is a drug metabolite of prednisone.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Mastocytosis is a rare myeloproliferative disease in which mast cells abnormally accumulate in the skin, bone marrow, intestine, liver, spleen, and lymph nodes." | 1.56 | Renal involvement and favorable outcome in a child with mastocytosis. ( Cho, H; Kim, JY; Kwon, GY; Lee, Y, 2020) |
| "In the cyclosporin-A- and prednisolone-treated groups, mastocytosis was suppressed, but worm expulsion was only slightly delayed, without statistical significance." | 1.32 | Effects of anti-allergic drugs on intestinal mastocytosis and worm expulsion of rats infected with Neodiplostomum seoulense. ( Chai, JY; Guk, SM; Hong, SJ; Kim, TH; Park, JH; Shin, EH, 2003) |
| "Systemic mastocytosis is a rare and chronic disorder characterized by a pathologically increased number of mast cells in various tissues and overproduction of mast cell mediators." | 1.29 | Anaphylactoid shock following Hymenoptera sting as a presenting symptom of systemic mastocytosis. ( de Monchy, JG; Kors, JW; van Doormaal, JJ, 1993) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (14.29) | 18.7374 |
| 1990's | 2 (28.57) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (28.57) | 2.80 |
| Authors | Studies |
|---|---|
| Molderings, GJ | 1 |
| Dumoulin, FL | 1 |
| Homann, J | 1 |
| Sido, B | 1 |
| Textor, J | 1 |
| Mücke, M | 1 |
| Qagish, GJ | 1 |
| Barion, R | 1 |
| Raithel, M | 1 |
| Klingmüller, D | 1 |
| Schäfer, VS | 1 |
| Hertfelder, HJ | 1 |
| Berdel, D | 1 |
| Tridente, G | 1 |
| Weinstock, LB | 1 |
| Afrin, LB | 1 |
| Cho, H | 1 |
| Kim, JY | 1 |
| Lee, Y | 1 |
| Kwon, GY | 1 |
| Shin, EH | 1 |
| Kim, TH | 1 |
| Hong, SJ | 1 |
| Park, JH | 1 |
| Guk, SM | 1 |
| Chai, JY | 1 |
| KIBEL, MA | 1 |
| KINGSLEY, HJ | 1 |
| Kors, JW | 1 |
| van Doormaal, JJ | 1 |
| de Monchy, JG | 1 |
| Takasaki, Y | 1 |
| Tsukasaki, K | 1 |
| Jubashi, T | 1 |
| Tomonaga, M | 1 |
| Kamihira, S | 1 |
| Makiyama, K | 1 |
| Assaf, C | 1 |
| Geilen, CC | 1 |
| Tebbe, B | 1 |
| Schulze, K | 1 |
| Orfanos, CE | 1 |
1 review available for prednisolone and Mast Cell Activation Disease
| Article | Year |
|---|---|
Adrenal insufficiency is a contraindication for omalizumab therapy in mast cell activation disease: risk for serum sickness.
Topics: Adrenal Insufficiency; Contraindications, Drug; Glucocorticoids; Humans; Immunologic Factors; Mast C | 2020 |
6 other studies available for prednisolone and Mast Cell Activation Disease
| Article | Year |
|---|---|
Renal involvement and favorable outcome in a child with mastocytosis.
Topics: Child; Female; Glomerulonephritis; Humans; Mastocytosis; Prednisolone; Proto-Oncogene Proteins c-kit | 2020 |
Effects of anti-allergic drugs on intestinal mastocytosis and worm expulsion of rats infected with Neodiplostomum seoulense.
Topics: Animals; Cimetidine; Cyclosporine; Histamine H1 Antagonists; Histamine H2 Antagonists; Hydroxyzine; | 2003 |
Mastocytosis; a report on two cases.
Topics: Cyproheptadine; Humans; Mast Cells; Mastocytosis; Prednisolone; Urticaria Pigmentosa | 1963 |
Anaphylactoid shock following Hymenoptera sting as a presenting symptom of systemic mastocytosis.
Topics: Adult; Aged; Anaphylaxis; Animals; Bee Venoms; Epinephrine; Female; Humans; Hymenoptera; Immunoglobu | 1993 |
Systemic mastocytosis with extensive polypoid lesions in the intestines; successful treatment with interferon-alpha.
Topics: Adult; Antineoplastic Agents; Biopsy; Bone Marrow Cells; Cell Division; Colonoscopy; Drug Therapy, C | 1998 |
Cutaneous mastocytosis.
Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents; Drug Therapy, Combination; Humans; Interferon alp | 2002 |